Thursday June 23, 2016
12:00 PM to 1:30 PM EST
Reducing Opioid Overdose Mortality:
Role of Community-Administered Naloxone
A Live Webcast Sponsored by:
Opioid Post-Marketing Requirements Consortium (OPC)/Campbell Alliance (Purdue Pharma, LP; Actavis; Endo Pharmaceuticals; Janssen Pharmaceuticals; Mallinckrodt, LLC; Pfizer; Rhodes Pharmaceuticals, LP; Roxane Laboratories; and Zogenix), Clinical Directors Network, Inc.(CDN), N2 PBRN Virtual Training Series (AHRQ, Grant No. 1P30-HS-021667)
This webcast is pending for up to 1.5 Prescribed credits by the American Academy of Family Physicians (AAFP)